Bell Potter think that DLX are making a bid at the bottom for ALS they have upgraded to accumulate with a 12 month target of $3.15 They see it asWACC and EPS accretive
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025